Funding Details
- Awarder
- Inbox
- Date Award
- March 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$150,000,000
Company Info
- Founders
- Nima Farzan
- Company Description
- Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
- Market
- Pain Management
- Location
-
Thousand Oaks,
California,
USA
- Coinvestors
- 5AM Ventures, Access Biotechnology, Alexandria Venture Investments, Blue Owl, Cormorant Asset Management, Deep Track Capital, Foresite Capital, Kern Capital, Qatar Investment Authority, Rock Springs Capital, Sanofi Ventures, UPMC Enterprises, Westlake Village BioPartners
Links